
Utah
Leading the Way into the
Genomics Era
Leaders
prepare Utah to use genetics
to prevent and treat asthma
April
12, 2006
Will there soon
be new personalized medicine
for those with asthma? Will family
health history enable health
care workers to more easily diagnose
the disease? How will genomics
impact individuals, families
and the society at large? The
Utah Department of Health (UDOH)
and Utah Asthma Task Force led
the nation by convening a first-of-its-kind
workshop to discuss questions
similar to these.
The one-day "Asthma's Future
in Utah: How Will Genomics Play
a Role?" workshop brought
together educators, policymakers,
industrial hygienists, nurses,
respiratory therapists and other
health professionals to build
on Utah's rich history of using
genetics and family history in
health care.
Kristina
Marsh, a 26-year-old with asthma
is hopeful for the future of
genomics and the outcome of
the workshop due to a lifetime
of difficulties managing her
own asthma. "I really believe
that genomics is the future of
medicine but especially asthma," Marsh
said. "It might mean that
there would someday be a controller
medication that works well for
me. It might also mean saving
years of trial-and-error and
frequent trips to the emergency
room."
The promises of the genomics
era have left leaders in health
care, education and government
to wonder how knowledge of genetics
will be used in the prevention
and treatment of common diseases
like asthma. The workshop focused
on how pharmacogenomics, family
health history, and the ethical,
legal and social issues surrounding
genomics can be integrated into
state asthma activities.
Workshop speakers ranged from
local experts to respected national
leaders in their fields, including:
· Paul Ray, Utah House of
Representatives (ethical, legal
and social issues)
· Jeffrey R. Botkin, MD,
MPH, Associate Vice President for
Research Integrity, University
of Utah (ethical, legal and social
issues)
· Wayne Anderson, PhD, Director,
GlaxoSmithKline Respiratory Disease
Genetics (pharmacogenomics or personalized
medicine)
· Marc S. Williams, MD,
FAAP, FACMG, Director, Intermountain
Health Care Clinical Genetics Institute
(genomics)
· Paul Eberle, Department
of Respiratory Care, Weber State
University (family health history)
Workshop attendees produced a
work plan for how genomics will
be integrated into asthma activities
in Utah. A draft of the work
plan is expected to be released
by July 2006.
Utah data indicates
approximately 9 percent of people
in Utah have asthma, up from
approximately 5 percent in 2001.
Asthma is one of the most common
chronic diseases affecting children
in the United States and often
causes repeated episodes of wheezing,
breathlessness, chest tightness,
and coughing that can interrupt
daily activities for those with
asthma. Although there is no
known cure, asthma symptoms can
generally be controlled. For
those interested in more information
about asthma and genomics, visit
www.health.utah.gov/asthma/genomics.html
# # #
|